Drugs & Targets Leukemia & Lymphoma Society accelerates payment to Celator Pharmaceuticals July 02, 2015Vol.41 No.26
Drugs & Targets FDA approves Ventana ALK (D5F3) CDx companion diagnostic assay for Xalkori June 19, 2015Vol.41 No.24
